Galmed Pharmaceuticals
GLMD
$0.38
Share price
-1.09%
Change (1 day)
-90.84%
Change (1 year)
Categories
Market capitalization of Galmed Pharmaceuticals (GLMD)
Market cap: $2.28 Million
As of May 2024 Galmed Pharmaceuticals has a market cap of $2.28 Million. This makes Galmed Pharmaceuticals the world's 8321th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Galmed Pharmaceuticals from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.28 M | 25.56% |
| 2023 | $1.82 M | -85.53% |
| 2022 | $12.6 M | -72.4% |
| 2021 | $45.65 M | -31.12% |
| 2020 | $66.28 M | -45.75% |
| 2019 | $0.12 B | -14.89% |
| 2018 | $0.14 B | 14.35% |
| 2017 | $0.12 B | 194.4% |
| 2016 | $42.64 M | -49.52% |
| 2015 | $84.47 M | 31.21% |
| 2014 | $64.38 M |
End of Day market cap according to different sources
On May 13th, 2024 the market cap of Galmed Pharmaceuticals was reported to be:
$2.33 Million
$2.33 Million
$1.94 Million
$1.95 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Evoke Pharma
EVOK | $4.09 M | 78.96% | 🇺🇸 USA |
 Endo International
ENDPQ | $0.14 M | -93.83% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | $0.75 B | 32,822.21% | 🇺🇸 USA |
 Catalent CTLT | $10.08 B | 440,633.13% | 🇺🇸 USA |